Who
Sierk Poetting
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, BioNTech SE.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $11.1M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 22 Apr 2026
- Last trade
- 12 May 2026
- Last filed
- 13 May 2026
Companies traded
Activity over time
1 Apr – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 May 2026filed 13 May 2026 | BNTX BioNTech SEoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,586 at $0.00 | filing |
| 12 May 2026filed 13 May 2026 | BNTX BioNTech SEoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,069 at $0.00 | filing |
| 12 May 2026filed 13 May 2026 | BNTX BioNTech SEoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,586 at $0.00 | filing |
| 12 May 2026filed 13 May 2026 | BNTX BioNTech SEoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,069 at $0.00 | filing |
| 22 Apr 2026filed 23 Apr 2026 | BNTX BioNTech SEBiotechnology | SEC FORM 4 Sold | $5.5M50,000 at $110.56 | filing |
| 22 Apr 2026filed 23 Apr 2026 | BNTX BioNTech SEBiotechnology | SEC FORM 4 Sold | $5.5M50,000 at $110.56 | filing |
News
Financial Comparison: MiMedx Group (NASDAQ:MDXG) versus BioNTech (NASDAQ:BNTX)BNTX · themarketsdaily.com · 21 Oct 2026
0 headlines in the last 90 days name Sierk Poetting; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.